Capital Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.1M Buy
31,596
+732
+2% +$261K 0.16% 110
2025
Q4
$10.1M Sell
30,864
-295
-0.9% -$93.6K 0.15% 117
2025
Q3
$8.79M Buy
31,159
+224
+0.7% +$65K 0.14% 118
2025
Q2
$8.64M Buy
30,935
+94
+0.3% +$26.6K 0.15% 114
2025
Q1
$9.61M Sell
30,841
-507
-2% -$150K 0.19% 104
2024
Q4
$8.17M Buy
31,348
+15
+0% +$4.45K 0.17% 113
2024
Q3
$10.1M Sell
31,333
-582
-2% -$190K 0.21% 99
2024
Q2
$9.97M Buy
31,915
+13
+0% +$3.82K 0.23% 94
2024
Q1
$9.07M Sell
31,902
-431
-1% -$126K 0.21% 97
2023
Q4
$9.31M Sell
32,333
-591
-2% -$161K 0.23% 93
2023
Q3
$8.85M Buy
32,924
+474
+1% +$118K 0.24% 89
2023
Q2
$7.2M Buy
32,450
+3,554
+12% +$825K 0.22% 91
2023
Q1
$6.99M Buy
28,896
+2,394
+9% +$588K 0.21% 100
2022
Q4
$6.96M Buy
26,502
+2,700
+11% +$724K 0.21% 100
2022
Q3
$5.37M Buy
23,802
+255
+1% +$61.8K 0.18% 109
2022
Q2
$5.73M Buy
23,547
+728
+3% +$178K 0.19% 104
2022
Q1
$5.52M Buy
22,819
+2,090
+10% +$480K 0.17% 113
2021
Q4
$4.66M Buy
20,729
+4,544
+28% +$959K 0.14% 119
2021
Q3
$3.44M Buy
16,185
+904
+6% +$208K 0.12% 135
2021
Q2
$3.73M Buy
15,281
+29
+0.2% +$7.13K 0.13% 131
2021
Q1
$3.79M Sell
15,252
-348
-2% -$83K 0.14% 123
2020
Q4
$3.59M Sell
15,600
-1,484
-9% -$342K 0.15% 112
2020
Q3
$4.34M Sell
17,084
-49,867
-74% -$12.4M 0.21% 97
2020
Q2
$15.8M Buy
66,951
+1,350
+2% +$308K 0.82% 33
2020
Q1
$13.3M Buy
65,601
+805
+1% +$176K 0.85% 32
2019
Q4
$15.6M Buy
64,796
+269
+0.4% +$59.3K 0.75% 35
2019
Q3
$12.5M Buy
64,527
+3,863
+6% +$741K 0.65% 37
2019
Q2
$11.2M Buy
60,664
+34,887
+135% +$6.25M 0.61% 37
2019
Q1
$4.9M Buy
25,777
+2,134
+9% +$408K 0.29% 84
2018
Q4
$4.6M Buy
23,643
+11
+0% +$2.15K 0.31% 73
2018
Q3
$4.9M Sell
23,632
-470
-2% -$92.6K 0.29% 76
2018
Q2
$4.45M Buy
24,102
+1,919
+9% +$339K 0.28% 75
2018
Q1
$3.78M Buy
22,183
+1,092
+5% +$200K 0.25% 84
2017
Q4
$3.67M Sell
21,091
-929
-4% -$164K 0.24% 91
2017
Q3
$4.11M Sell
22,020
-3,483
-14% -$617K 0.28% 83
2017
Q2
$4.39M Buy
25,503
+3,172
+14% +$516K 0.31% 74
2017
Q1
$3.66M Buy
22,331
+5,147
+30% +$855K 0.28% 82
2016
Q4
$2.51M Buy
17,184
+13,207
+332% +$1.99M 0.21% 106
2016
Q3
$663K Buy
3,977
+89
+2% +$15.1K 0.06% 235
2016
Q2
$592K Sell
3,888
-156
-4% -$24.3K 0.06% 239
2016
Q1
$606K Sell
4,044
-397
-9% -$59K 0.06% 228
2015
Q4
$721K Buy
4,441
+82
+2% +$12.9K 0.07% 200
2015
Q3
$603K Buy
4,359
+362
+9% +$57.1K 0.07% 210
2015
Q2
$614K Buy
3,997
+162
+4% +$26K 0.07% 216
2015
Q1
$613K Sell
3,835
-34
-0.9% -$5.36K 0.06% 221
2014
Q4
$616K Sell
3,869
-19
-0.5% -$2.96K 0.07% 221
2014
Q3
$546K Sell
3,888
-348
-8% -$45.4K 0.06% 218
2014
Q2
$501K Sell
4,236
-222
-5% -$25.7K 0.06% 231
2014
Q1
$550K Buy
4,458
+2
+0% +$243 0.07% 224
2013
Q4
$508K Buy
+4,456
New +$507K 0.07% 223

Other funds holding AMGN

Capital Investment Advisors's AMGN Position: Q1 2026 in Review

Capital Investment Advisors increased its Amgen (AMGN) stake by 2.4% in Q1 2026, buying an estimated $261K and bringing the position to 31,596 shares worth $11.1M. The position accounts for 0.16% of the portfolio, ranked #110.

Capital Investment Advisors first reported a position in AMGN in Q4 2013 and has held it in 50 quarters since. The position peaked at $15.8M in Q2 2020. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Capital Investment Advisors held 31,596 shares of Amgen worth $11.1M as of Q1 2026.
  • Capital Investment Advisors bought 732 Amgen shares in Q1 2026, an estimated $261K.
  • Amgen made up 0.16% of Capital Investment Advisors's portfolio in Q1 2026, its #110 holding.
  • Capital Investment Advisors first reported a position in Amgen in Q4 2013 and has held it in 50 quarters since.
  • Capital Investment Advisors's Amgen position peaked at $15.8M in Q2 2020.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Capital Investment Advisors's 13F filing for Q1 2026, filed 16 Apr 2026.